cSMART Liquid Biopsy and Dynamic Monitor of NSCLC Patients in Inner-Mongolia China

ctDNA Dynamic Monitoring and Its Role of Prognosis in Stage I NSCLS by NGS

NCT03172156 ·Status: COMPLETED

Perioperative and Postoperative Circulating Tumor Cell Monitoring in Different Stage of NSCLC

NCT07186855 ·Status: COMPLETED

The Feasibility of Dynamic Liquid Biopsy Monitoring During Neoadjuvant Treatment for EGFR-mutated NSCLC

NCT06287593 ·Status: NOT_YET_RECRUITING ·Phase: NA

LIquid Biopsy to prEdict Responses To First-line immunotherapY in Metastatic Non-small Cell LUNG Cancer. LIBERTY LUNG

NCT04790682 ·Status: RECRUITING ·Phase: NA

Liquid Biopsy in Advanced Oligometastatic NSCLC Receiving Surgery

NCT05648370 ·Status: UNKNOWN

Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated NSCLC Patients

NCT04566432 ·Status: RECRUITING

Liquid Biopsy for Detection of Driver Mutation in NSCLC

NCT02778854 ·Status: UNKNOWN

Monitoring the Changes of Tumor-related Biomarkers Before and After Pulmonary Nodule Biopsy.

NCT03397355 ·Status: UNKNOWN

ctDNA-MRD in Stage IIIB-C NSCLC Patients Treated With Induction Chemoimmunotherapy

NCT05822284 ·Status: NOT_YET_RECRUITING

Low-dose Protocol for Computed Tomography-guided Lung Biopsy

NCT02971176 ·Status: COMPLETED ·Phase: NA

A Prospective Study to Evaluate the Consistency of Next-Generation Sequencing(NGS)-Panels by Using Malignant Hydrothorax Form NSCLC

NCT03546452 ·Status: UNKNOWN

Explore Intra-tumor Heterogeneity and Prognostic Value of Postoperative Blood ctDNA of ⅡA - ⅢA Stage Non-squamous NSCLC Based on the Capture-based Sequencing and UMI Technology of Burning Rock

NCT03337711 ·Status: UNKNOWN

Mutation Detection of EBUS-TBNA Specimens Using NGS

NCT02420405 ·Status: COMPLETED ·Phase: NA

Benign/Malignant Pulmonary Nodule Classification Based on High-throughput Whole-genome Methylation Sequencing(GM-seq)

NCT05415670 ·Status: COMPLETED

MRD-guided Prognosis Prediction and Adjuvant Treatment Based on CTC and ctDNA in NSCLC

NCT06198868 ·Status: RECRUITING

cfDNA Methylation Assay for Clinical Evaluation of Patients With Stage IA Lung Cancer After Ablation Operation

NCT04413656 ·Status: UNKNOWN ·Phase: NA

ALK/ROS1/MET Mutations on Plasma ctDNA in Patients With NSCLC

NCT02946216 ·Status: UNKNOWN

Molecular Imaging Visualization of Tumor Heterogeneity in Non-small Cell Lung Cancer

NCT04553601 ·Status: UNKNOWN ·Phase: NA

Multiple Omics Sequencing Technologies in Predicting the Efficacy and Monitoring the Recurrence of Non-Small Cell Lung Cancer

NCT07057102 ·Status: RECRUITING

Effects of Different Genetic Mutations on Prognosis in sMPLC Adenocarcinoma Patients

NCT03764371 ·Status: UNKNOWN

Clinical Evaluation of Genetron Lung Cancer Panel in Non-small Cell Lung Cancer Patients

NCT05023746 ·Status: COMPLETED

Non-Invasive ctDNA Methylation Detection for Lung Nodule Patients

NCT03685669 ·Status: UNKNOWN

Novel Detection System for Lung Cancer Curative Effect Monitoring

NCT02666755 ·Status: UNKNOWN

Predicting Non-small Cell Lung Cancer (NSCLC) Lymph Node Metastasis: Integrating Circulating Tumor DNA (ctDNA) Mutation/ Methylation Profiling With Positron Emission Tomography-computed Tomography (PET-CT) Scan

NCT06358222 ·Status: RECRUITING

Identifying Genomic Mutations of Multiple Primary Lung Cancers by Circulating Tumor DNA

NCT02833467 ·Status: UNKNOWN